Labcorp Holdings (LH)
Labcorp Holdings on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, federal contracts, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-medical laboratories.
2.7M
Short interest
settlement 2026-09-30
3.0
Days to cover
-0.3 days vs prior
31.5%
Short share of volume
2026-10-09
18
Fails to deliver
settlement 2026-09-14
Tue 27 Oct
Next earnings
estimated date
-$3.2M
Insider flow, 90 days
0 buys, 5 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in LH is 2,684,363 shares, up 581,061 shares over the last month. Over the last 48 readings it ranged from 1,831,926 shares (14 February 2025) to 3,559,484 shares (30 June 2025). At the reported average volume of 893K shares a day that is 3.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/lh" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 2,684,363 | +9.6% | 892,507 | 3.01 |
| 2026-09-15 | 2,448,617 | +16.4% | 740,750 | 3.31 |
| 2026-08-31 | 2,103,302 | +8.5% | 660,410 | 3.18 |
| 2026-08-14 | 1,938,163 | -7.5% | 505,328 | 3.84 |
| 2026-07-31 | 2,094,544 | -23.1% | 959,198 | 2.18 |
| 2026-07-15 | 2,721,939 | -3.8% | 575,165 | 4.73 |
| 2026-06-30 | 2,830,398 | -13.3% | 743,863 | 3.80 |
| 2026-06-15 | 3,264,521 | -4.7% | 544,798 | 5.99 |
| 2026-05-29 | 3,426,602 | +1.7% | 588,520 | 5.82 |
| 2026-05-15 | 3,369,697 | +6.8% | 718,250 | 4.69 |
| 2026-04-30 | 3,156,205 | -2.5% | 766,867 | 4.12 |
| 2026-04-15 | 3,236,989 | +1.4% | 539,780 | 6.00 |
| 2026-03-31 | 3,192,818 | +6.7% | 585,772 | 5.45 |
| 2026-03-13 | 2,992,293 | -6.5% | 505,239 | 5.92 |
| 2026-02-27 | 3,200,111 | +6.0% | 825,922 | 3.87 |
| 2026-02-13 | 3,017,792 | -5.4% | 724,480 | 4.17 |
| 2026-01-30 | 3,191,344 | +5.2% | 787,184 | 4.05 |
| 2026-01-15 | 3,032,698 | -2.6% | 816,386 | 3.71 |
| 2025-12-31 | 3,115,323 | -1.2% | 637,594 | 4.89 |
| 2025-12-15 | 3,152,732 | +1.2% | 613,450 | 5.14 |
| 2025-11-28 | 3,115,917 | -3.0% | 744,226 | 4.19 |
| 2025-11-14 | 3,211,771 | +19.6% | 1,271,317 | 2.53 |
| 2025-10-31 | 2,684,426 | +10.1% | 973,075 | 2.76 |
| 2025-10-15 | 2,438,588 | -2.8% | 571,423 | 4.27 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of LH volume is 31.5%, down 7.1 points over the last five sessions. Over the last 30 readings it ranged from 31.0% (22 September 2026) to 74.8% (16 September 2026). The latest reading sits at the bottom of that range. The latest reading is 19.0 points below the 30-session average of 50.5%, on 232K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 73K | 232K | 31.5% | 391 |
| 2026-10-08 | 114K | 275K | 41.6% | 1 |
| 2026-10-07 | 126K | 239K | 52.8% | 19 |
| 2026-10-06 | 164K | 373K | 43.9% | 0 |
| 2026-10-05 | 144K | 248K | 58.0% | 1,107 |
| 2026-10-02 | 87K | 225K | 38.6% | 0 |
| 2026-10-01 | 70K | 211K | 33.1% | 301 |
| 2026-09-30 | 104K | 213K | 49.1% | 0 |
| 2026-09-29 | 132K | 211K | 62.8% | 630 |
| 2026-09-28 | 150K | 242K | 62.0% | 18 |
| 2026-09-25 | 201K | 346K | 58.2% | 0 |
| 2026-09-24 | 125K | 325K | 38.6% | 181 |
| 2026-09-23 | 112K | 316K | 35.2% | 54 |
| 2026-09-22 | 246K | 794K | 31.0% | 26 |
| 2026-09-21 | 77K | 168K | 45.7% | 9 |
| 2026-09-18 | 195K | 350K | 55.7% | 1,022 |
| 2026-09-17 | 117K | 206K | 56.5% | 0 |
| 2026-09-16 | 161K | 215K | 74.8% | 0 |
| 2026-09-15 | 283K | 406K | 69.6% | 34,609 |
| 2026-09-14 | 155K | 289K | 53.6% | 1,200 |
| 2026-09-11 | 161K | 368K | 43.8% | 48 |
| 2026-09-10 | 379K | 635K | 59.8% | 661 |
| 2026-09-09 | 137K | 438K | 31.4% | 40 |
| 2026-09-08 | 145K | 284K | 51.1% | 236 |
| 2026-09-04 | 102K | 188K | 54.2% | 24 |
| 2026-09-03 | 133K | 212K | 63.0% | 52 |
| 2026-09-02 | 119K | 250K | 47.7% | 2,440 |
| 2026-09-01 | 127K | 202K | 63.2% | 85 |
| 2026-08-31 | 118K | 207K | 57.1% | 217 |
| 2026-08-28 | 100K | 192K | 52.0% | 13 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 September 2026, the fails-to-deliver balance in LH is 18 shares, down 124 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (20 February 2026) to 7,999 shares (23 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-14 | 18 | $311.54 | $6K |
| 2026-08-28 | 142 | $336.54 | $48K |
| 2026-08-06 | 6,608 | $313.96 | $2.1M |
| 2026-08-05 | 1,189 | $312.34 | $371K |
| 2026-08-04 | 1,198 | $307.42 | $368K |
| 2026-07-27 | 3,454 | $296.77 | $1.0M |
| 2026-07-23 | 7,999 | $281.46 | $2.3M |
| 2026-07-20 | 382 | $283.36 | $108K |
| 2026-07-10 | 60 | $277.63 | $17K |
| 2026-07-07 | 480 | $284.39 | $137K |
| 2026-06-30 | 98 | $279.58 | $27K |
| 2026-06-17 | 676 | $264.76 | $179K |
| 2026-06-09 | 53 | $262.01 | $14K |
| 2026-06-04 | 2 | $258.92 | $518 |
| 2026-06-02 | 937 | $256.87 | $241K |
| 2026-05-26 | 75 | $259.93 | $19K |
| 2026-05-20 | 690 | $253.69 | $175K |
| 2026-05-19 | 796 | $255.57 | $203K |
| 2026-04-28 | 4 | $263.43 | $1K |
| 2026-04-15 | 2,950 | $268.87 | $793K |
| 2026-04-13 | 13 | $260.93 | $3K |
| 2026-03-25 | 13 | $266.12 | $3K |
| 2026-03-24 | 3,007 | $264.42 | $795K |
| 2026-03-17 | 1,010 | $266.85 | $270K |
| 2026-03-13 | 7,142 | $262.91 | $1.9M |
| 2026-03-10 | 241 | $273.61 | $66K |
| 2026-03-06 | 144 | $275.92 | $40K |
| 2026-03-05 | 144 | $280.85 | $40K |
| 2026-02-23 | 2,771 | $282.67 | $783K |
| 2026-02-20 | 1 | $282.48 | $282 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at LH reported 5 open-market sells worth $3.2M in the last 90 days and no open-market buys. Latest filing: ANDERSON KERRII B (Director) on 2026-08-17.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | ANDERSON KERRII B | Director | Sell | 3K | $318.02 | $954K | 7K |
| 2026-08-11 | Schechter Adam H | President & CEO | Sell | 5K | $320.37 | $1.5M | 103K |
| 2026-08-04 | Summy Amy B. | EVP, Chief Marketing Officer | Sell | 924 | $306.74 | $283K | 7K |
| 2026-08-03 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 1K | $309.23 | $414K | 2K |
| 2026-08-03 | Wilkinson Peter J | SVP, Chief Accounting Officer | Option exercise | 1K | $209.25 | $280K | 3K |
| 2026-08-03 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 82 | $309.22 | $25K | 2K |
| 2026-07-02 | Vaughn Bryan T | EVP and President, Diagnostics | Sell | 234 | $286.19 | $67K | 7K |
| 2026-07-02 | Kyle Kathryn W | EVP, Chief Legal Officer | Sell | 92 | $286.19 | $26K | 4K |
| 2026-07-01 | Vaughn Bryan T | EVP and President, Diagnostics | Tax withholding | 93 | $283.88 | $26K | 7K |
| 2026-07-01 | Vaughn Bryan T | EVP and President, Diagnostics | Option exercise | 327 | price not stated in the filing | not stated | 7K |
| 2026-07-01 | Kyle Kathryn W | EVP, Chief Legal Officer | Tax withholding | 73 | $283.88 | $21K | 4K |
| 2026-07-01 | Kyle Kathryn W | EVP, Chief Legal Officer | Option exercise | 256 | price not stated in the filing | not stated | 4K |
| 2026-06-08 | Kyle Kathryn W | EVP, Chief Legal Officer | Sell | 762 | $263.89 | $201K | 4K |
| 2026-05-11 | Schechter Adam H | President & CEO | Sell | 6K | $254.50 | $1.5M | 107K |
| 2026-03-27 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 2K | $267.05 | $436K | 2K |
| 2026-03-27 | Meltzer Jonathan C | EVP, Operations | Sell | 839 | $267.05 | $224K | 4K |
| 2026-03-26 | Schechter Adam H | President & CEO | Tax withholding | 26K | $268.38 | $7.0M | 113K |
| 2026-03-26 | Schechter Adam H | President & CEO | Grant | 58K | $0.00 | $0 | 139K |
| 2026-03-26 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Tax withholding | 1K | $268.38 | $394K | 13K |
| 2026-03-26 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Grant | 3K | $0.00 | $0 | 14K |
| 2026-03-26 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Tax withholding | 5K | $268.38 | $1.2M | 11K |
| 2026-03-26 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Grant | 9K | $0.00 | $0 | 16K |
| 2026-03-26 | Wilkinson Peter J | SVP, Chief Accounting Officer | Tax withholding | 755 | $268.38 | $203K | 3K |
| 2026-03-26 | Wilkinson Peter J | SVP, Chief Accounting Officer | Grant | 2K | $0.00 | $0 | 4K |
| 2026-03-26 | Vaughn Bryan T | EVP, Diagnostics | Tax withholding | 451 | $268.38 | $121K | 7K |
| 2026-03-26 | Vaughn Bryan T | EVP, Diagnostics | Grant | 2K | $0.00 | $0 | 7K |
| 2026-03-26 | van der Vaart Sandra D | EVP, Corporate Affairs | Tax withholding | 3K | $268.38 | $731K | 6K |
| 2026-03-26 | van der Vaart Sandra D | EVP, Corporate Affairs | Grant | 6K | $0.00 | $0 | 9K |
| 2026-03-26 | Summy Amy B. | EVP, Chief Marketing Officer | Tax withholding | 2K | $268.38 | $493K | 8K |
| 2026-03-26 | Summy Amy B. | EVP, Chief Marketing Officer | Grant | 4K | $0.00 | $0 | 10K |
| 2026-03-26 | Oyegunwa Akinbolade | EVP, CIO & CTO | Tax withholding | 382 | $268.38 | $103K | 5K |
| 2026-03-26 | Oyegunwa Akinbolade | EVP, CIO & CTO | Grant | 1K | $0.00 | $0 | 5K |
| 2026-03-26 | Meltzer Jonathan C | EVP, Operations | Tax withholding | 711 | $268.38 | $191K | 4K |
| 2026-03-26 | Meltzer Jonathan C | EVP, Operations | Grant | 2K | $0.00 | $0 | 5K |
| 2026-03-26 | Kyle Kathryn W | EVP, Chief Legal Officer | Tax withholding | 451 | $268.38 | $121K | 5K |
| 2026-03-26 | Kyle Kathryn W | EVP, Chief Legal Officer | Grant | 2K | $0.00 | $0 | 5K |
| 2026-03-26 | GRAHAM ANITA Z | EVP, CHRO | Tax withholding | 3K | $268.38 | $773K | 5K |
| 2026-03-26 | GRAHAM ANITA Z | EVP, CHRO | Grant | 7K | $0.00 | $0 | 8K |
| 2026-03-26 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Tax withholding | 863 | $268.38 | $232K | 36K |
| 2026-03-26 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Grant | 2K | $0.00 | $0 | 37K |
| 2026-03-26 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Tax withholding | 4K | $268.38 | $1.1M | 35K |
| 2026-03-26 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Grant | 9K | $0.00 | $0 | 39K |
| 2026-03-26 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Tax withholding | 481 | $268.38 | $129K | 5K |
| 2026-03-26 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | Grant | 1K | $0.00 | $0 | 5K |
| 2026-03-03 | Schechter Adam H | President & CEO | Sell | 9K | $279.96 | $2.4M | 81K |
| 2026-02-27 | van der Vaart Sandra D | EVP, Corporate Affairs | Sell | 548 | $284.91 | $156K | 3K |
| 2026-02-27 | van der Vaart Sandra D | EVP, Corporate Affairs | Sell | 548 | $284.91 | $156K | 3K |
| 2026-02-24 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | Sell | 2K | $286.31 | $429K | 30K |
| 2026-02-19 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 666 | $277.94 | $185K | 2K |
| 2026-02-12 | Meltzer Jonathan C | EVP, Operations | Sell | 87 | $290.42 | $25K | 3K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON19 Form 144 notices on file for LH worth $16.2M at the prices reported; 3 in the last 90 days worth $2.7M. Latest: KERRII B ANDERSON filed on 2026-08-17 to sell 3,000 shares ($954K) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-17 | KERRII B ANDERSONDirector | 3K | $954K | 0.004% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | Schechter Adam HOfficer, Director | 5K | $1.5M | 0.006% | 2026-08-11 | Fidelity Brokerage Services LLC |
| 2026-08-04 | Summy Amy B.Officer | 924 | $283K | 0.001% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-07-02 | Vaughn Bryan TOfficer | 234 | $67K | 0.000% | 2026-07-02 | Fidelity Brokerage Services LLC |
| 2026-07-02 | Kyle Kathryn WOfficer | 92 | $26K | 0.000% | 2026-07-02 | Fidelity Brokerage Services LLC |
| 2026-07-01 | van der Vaart Sandra DFormer Officer | 7K | $2.0M | 0.009% | 2026-07-01 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Kyle Kathryn WOfficer | 762 | $201K | 0.001% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-05-11 | Schechter Adam HOfficer, Director | 6K | $1.5M | 0.007% | 2026-05-11 | Fidelity Brokerage Services LLC |
| 2026-05-06 | van der Vaart Sandra DFormer Officer | 6K | $1.6M | 0.008% | 2026-05-06 | Fidelity Brokerage Services LLC |
| 2026-03-27 | Meltzer Jonathan COfficer | 839 | $224K | 0.001% | 2026-03-27 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Schechter Adam HOfficer, Director | 9K | $2.4M | 0.011% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-02-27 | van der Vaart Sandra DOfficer | 548 | $156K | 0.001% | 2026-02-27 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Caveney Brian JOfficer | 2K | $429K | 0.002% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-12 | Meltzer Jonathan COfficer | 87 | $25K | 0.000% | 2026-02-12 | Fidelity Brokerage Services LLC |
| 2026-02-11 | Schechter Adam HOfficer, Director | 5K | $1.5M | 0.006% | 2026-02-11 | Fidelity Brokerage Services LLC |
| 2026-02-10 | Meltzer Jonathan COfficer | 91 | $25K | 0.000% | 2026-02-10 | Fidelity Brokerage Services LLC |
| 2026-02-09 | Meltzer Jonathan COfficer | 88 | $24K | 0.000% | 2026-02-09 | Fidelity Brokerage Services LLC |
| 2025-11-12 | Schechter Adam HOfficer, Director | 6K | $1.5M | 0.007% | 2025-11-11 | Fidelity Brokerage Services LLC |
| 2025-10-31 | Parham Richelle PDirector | 7K | $1.8M | 0.008% | 2025-10-31 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of LH in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (6,201,512 shares), filed 2026-04-28 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-28 | 13G | Vanguard Capital Managementinvestment adviser | 6.2M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 14 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding LH at their latest 13F. JSON8 of the 30 tracked managers held LH at their latest 13F, $142.3M in total at quarter-end prices. Millennium Management is the largest at $63.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 228K | $63.9M | 0.02% | +103K |
| Point72 Asset Management | 2026-06-30 | 137K | $38.5M | 0.04% | -122K |
| AQR Capital Management | 2026-06-30 | 61K | $16.9M | 0.01% | +7K |
| D. E. Shaw & Co. | 2026-06-30 | 40K | $11.2M | 0.01% | new |
| Citadel Advisors | 2026-06-30 | 35K | $9.9M | 0.00% | -36K |
| Bridgewater Associates | 2026-06-30 | 3K | $783K | 0.00% | -8K |
| Two Sigma Investments | 2026-06-30 | 3K | $756K | 0.00% | new |
| Fisher Asset Management | 2026-06-30 | 1K | $364K | 0.00% | -347 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Labcorp Holdings reported revenue of $3.73B, up 5.8% from the same quarter a year earlier, and net income of $298.7M (3.64 diluted EPS). In FY 2025 it generated $1.64B of operating cash flow and spent $450.0M on buybacks and $240.7M on dividends. As of 2026-06-30, cash was $141.8M against $5.86B of debt.
- Cash
- $141.8M
- Debt
- $5.86B
- Equity
- $8.61B
- Total assets
- $18.53B
- Shares outstanding
- 81,100,000
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $3.73B | $298.7M | 8.0% | 3.64 |
| Q1 FY 2026 | 2026-03-31 | $3.54B | $277.8M | 7.9% | 3.35 |
| Q4 FY 2025derived | 2025-12-31 | $3.52B | $164.7M | 4.7% | n/a |
| Q3 FY 2025 | 2025-09-30 | $3.56B | $261.1M | 7.3% | 3.12 |
| Q2 FY 2025 | 2025-06-30 | $3.53B | $237.9M | 6.7% | 2.84 |
| Q1 FY 2025 | 2025-03-31 | $3.35B | $212.8M | 6.4% | 2.52 |
| Q4 FY 2024derived | 2024-12-31 | $3.33B | $143.4M | 4.3% | n/a |
| Q3 FY 2024 | 2024-09-30 | $3.28B | $169.3M | 5.2% | 2.00 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $13.95B | $876.5M | $1.64B | $434.5M | $450.0M | $240.7M |
| FY 2024 | 2024-12-31 | $13.01B | $746.0M | $1.59B | $489.9M | $250.1M | $243.1M |
| FY 2023 | 2023-12-31 | $12.16B | $418.0M | $1.33B | $453.6M | $1.00B | $254.0M |
| FY 2022 | 2022-12-31 | $11.86B | $1.28B | $1.96B | $429.3M | $1.10B | $195.2M |
| FY 2021 | 2021-12-31 | $13.14B | $2.38B | $3.11B | $421.5M | $1.67B | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-04 from the cover page.
Federal contracts
The largest contract actions for Labcorp Holdings and its subsidiaries. JSON26 contract actions on file for LH: $33.4M obligated in the last 90 days and $36.9M in the last 12 months across 5 awarding agencies. The largest was $7.3M from the Department of Veterans Affairs on 2026-09-29 (reference laboratory services task order). This covers the largest contract actions, not every award, and agencies report late.
| Action date | Agency | Amount | Type | Description |
|---|---|---|---|---|
| 2026-10-09 | Department of JusticeFederal Prison System / Bureau of Prisons | $42K | new awardbpa call | NATIONAL LABORATORY TESTING SERVICES FOR VARIOUS INSTITUTIONS. INVOICE AMT $41,897.48USAspending |
| 2026-10-09 | Department of JusticeFederal Prison System / Bureau of Prisons | $8K | mod P00001bpa call | FCI LEAVENWORTH LABCORP SERVICES FY27 OCTOBER 2026 GENERAL POPULATION IDV: 15BNAS26A00000023 FSS #: V797D-50532USAspending |
| 2026-10-09 | Department of JusticeFederal Prison System / Bureau of Prisons | $664 | mod P00001bpa call | FCI LEAVENWORTH LABCORP SERVICES FY27 OCTOBER 2026 US MARSHAL POPULATION IDV: 15BNAS26A00000023 FSS #: V797D-50532USAspending |
| 2026-10-05 | Department of Veterans AffairsDepartment of Veterans Affairs | $999K | new awardbpa call | VISN WIDE BPA FOR LABORATORY TESTING AND ANALYSIS SERVICESUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $3.0M | new awardbpa call | VISN WIDE BPA FOR LABORATORY TESTING AND ANALYSIS SERVICESUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $2.6M | new awardbpa call | EO 14398 REQUIREMENT. FY27 LAB SERVICESUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $2.1M | new awardbpa call | REFERENCE LAB CONTRACT UNDER SIN 621IIUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $2.0M | new awardbpa call | VISN WIDE BPA FOR LABORATORY TESTING AND ANALYSIS SERVICESUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $2.0M | new awardbpa call | REFERENCE LAB CONTRACT UNDER SIN 621IIUSAspending |
| 2026-10-01 | Department of Veterans AffairsDepartment of Veterans Affairs | $1.5M | new awarddelivery order | VISN 19 SHORT TERM REFERENCE LABORATORY TESTINGUSAspending |
| 2026-09-29 | Department of Veterans AffairsDepartment of Veterans Affairs | $7.3M | new awarddelivery order | REFERENCE LABORATORY SERVICES TASK ORDERUSAspending |
| 2026-09-29 | Department of Veterans AffairsDepartment of Veterans Affairs | $3.5M | new awarddelivery order | LABCORP - HEMATOLOGY MOLECULAR TESTING SERVICESUSAspending |
| 2026-09-20 | Department of Health and Human ServicesFood and Drug Administration | -$190K | mod P00001delivery order | COVID-19 TESTING FOR FDA INSPECTIONAL ACTIVITIES FOR A TOTAL OF 2,500 ORA EMPLOYEESUSAspending |
| 2026-09-19 | Department of Health and Human ServicesIndian Health Service | $1.0M | new awarddelivery order | NAIHS - REFERRAL CLINICAL LAB TESTING SERVICES FOR THE LABORATORY DEPARTMENT AT THE KAYENTA HEALTH CENTERUSAspending |
| 2026-09-19 | Department of Health and Human ServicesIndian Health Service | $100K | new awarddelivery order | NAIHS-REFERRAL CLINICAL LAB TESTING SERVICES FOR THE LAB DEPARTMENT AT THE IHHC.USAspending |
| 2026-09-17 | Department of Health and Human ServicesIndian Health Service | $1.0M | new awarddelivery order | NAIHS-REFERRAL CLINICAL LAB TESTING SERVICES - NNMCUSAspending |
| 2026-09-17 | Department of Health and Human ServicesIndian Health Service | $987K | new awarddelivery order | REFERRAL CLINICAL LAB TESTING SERVICES FOR GSUUSAspending |
| 2026-09-04 | Department of Health and Human ServicesCenters for Disease Control and Prevention | $331K | mod P00003delivery order | EXERCISING AN OPTION_EO 14398USAspending |
| 2026-08-24 | Department of Veterans AffairsDepartment of Veterans Affairs | $880K | new awarddelivery order | REFERENCE LABORATORY TESTINGUSAspending |
| 2026-08-02 | Department of JusticeFederal Prison System / Bureau of Prisons | $9K | new awardbpa call | FCI THREE RIVERS FY26 3RD AND 4TH QUARTER LABORATORY TESTING SERVICES AGAINST FSS NUMBER V797D-50532USAspending |
| 2026-07-23 | Department of Homeland SecurityU.S. Immigration and Customs Enforcement | $3.2M | new awardbpa call | THIS CONTRACT PROVIDES ICE HEALTH SERVICE CORPS WITH LABORATORY SERVICES AT VARIOUS DETENTION FACILITIES.USAspending |
| 2026-07-20 | Department of Veterans AffairsDepartment of Veterans Affairs | $544K | new awarddelivery order | REFERENCE LABS - DETROITUSAspending |
| 2026-07-17 | Department of LaborOffice of the Assistant Secretary for Administration and Management | $380K | mod P00008delivery order | JOB CORPS NATIONAL LABORATORY TESTING SUPPORT/ FULLY FUND OPTION PERIOD 1USAspending |
| 2026-07-07 | Department of JusticeFederal Prison System / Bureau of Prisons | $288K | new awardbpa call | NATIONAL LABORATORY TESTING SERVICES FOR VARIOUS INSTITUTIONS.USAspending |
| 2026-06-29 | Department of Veterans AffairsDepartment of Veterans Affairs | $2.4M | new awardbpa call | EMERGENCY BRIDGE CONTRACT - REFERENCE LAB TESTING SERVICES FOR MULTISITE VA MEDICAL CENTERSUSAspending |
| 2026-06-29 | Department of Veterans AffairsDepartment of Veterans Affairs | $840K | new awarddelivery order | ORDERING PERIOD 2 DO/TO- REFERENCE LABORATORY TESTING SERVICES FOR VA FACILITIES.USAspending |
What this page is
Labcorp Holdings in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Labcorp Holdings (LH), SEC CIK 920148, listed on NYSE, classified by the SEC as services-medical laboratories. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-28.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Federal contracts
- USAspending.govSource: USAspending.gov.The largest contract actions each day, as agencies report them (up to 90 days late). Latest 2026-10-09.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-17.JSON and CSV
- Company record
- EDGAR filing index for CIK 920148Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-medical laboratories
Other company pages
Datasets
Frequently Asked Questions
How much of LH is sold short?
2,684,363 shares were held short at the 2026-09-30 settlement, 3.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is LH's daily short volume?
On 2026-10-09, 73,282 of the 232,396 LH shares reported to FINRA were sold short, 31.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does LH have fails to deliver?
The SEC's latest file shows 18 LH shares failed to deliver at settlement 2026-09-14. Fails are reported per settlement date and published twice a month with a lag.
Are LH insiders buying or selling?
Insiders at LH reported 5 open-market sells worth $3.2M in the last 90 days and no open-market buys. Latest filing: ANDERSON KERRII B (Director) on 2026-08-17.
Have LH insiders filed to sell?
19 Form 144 notices on file for LH worth $16.2M at the prices reported; 3 in the last 90 days worth $2.7M. Latest: KERRII B ANDERSON filed on 2026-08-17 to sell 3,000 shares ($954K) from 2026-08-17.
Who owns 5% or more of LH?
1 holder reports 5% or more of LH in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (6,201,512 shares), filed 2026-04-28 for an event on 2026-03-31.
What did LH report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Labcorp Holdings reported revenue of $3.73B, up 5.8% from the same quarter a year earlier, and net income of $298.7M (3.64 diluted EPS). In FY 2025 it generated $1.64B of operating cash flow and spent $450.0M on buybacks and $240.7M on dividends. As of 2026-06-30, cash was $141.8M against $5.86B of debt.
Which tracked 13F managers own LH?
8 of the 30 tracked 13F managers held LH shares at their latest filing, $142.3M in all. The largest: Izzy Englander's Millennium Management (228K shares, $63.9M), Steve Cohen's Point72 Asset Management (137K shares, $38.5M), Cliff Asness's AQR Capital Management (61K shares, $16.9M), D. E. Shaw & Co. (40K shares, $11.2M), Ken Griffin's Citadel Advisors (35K shares, $9.9M), Ray Dalio's Bridgewater Associates (3K shares, $783K). The table above lists all 8.
How much federal contract money did LH receive?
$33.4M was obligated to Labcorp Holdings and its subsidiaries in the last 90 days and $36.9M in the last 12 months, counting the largest contract actions on USAspending, not every award. Obligations are not revenue; they are spent over each contract's life.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.